China challenges US in new drugs after industry transformation



China challenges US in new drugs after industry transformation
In barely a decade, China has transformed from a maker of cheap generic copies of Western medicines into a global powerhouse of pharmaceutical innovation.
The country now only trails the United States in novel drugs under development, with a 29 per cent share, according to McKinsey. International pharmaceutical companies are beating a path to China’s shores to license next-generation treatments for cancer, autoimmune diseases and other disorders.
Government support, including regulatory and…

  • Related Posts

    HDFC Bank Deputy MD Kaizad Bharucha resigns; RBI approval sought for December 31 exit

    HDFC Bank Deputy Managing Director Kaizad Bharucha has decided to step down after more than three decades with the lender, with his exit scheduled for December 31, 2026, subject to…

    Continue reading
    ‘Much appreciated ‘: Musk replies to Reliance’s statment on Jio awaiting govt clearances

    SpaceX CEO Elon Musk responded to Reliance Industries’ statement on Starlink’s proposed India entry. Replying to Reliance’s statement on X, formerly known as Twitter, Musk wrote: ‘Much appreciated’ SpaceX CEO…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *